Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

BioVaxys Technology Corp (CN: BIOV)

 
BIOV Technical Analysis
4
As on 14th Nov 2024 BIOV STOCK Price closed @ 0.07 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.04 & Strong Buy for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BIOVSTOCK Price

Open 0.07 Change Price %
High 0.07 1 Day 0.00 0.00
Low 0.06 1 Week 0.00 0.00
Close 0.07 1 Month 0.02 40.00
Volume 734941 1 Year 0.04 133.33
52 Week High 0.10 | 52 Week Low 0.02
 
CN Canada Most Active Stocks
BTC 0.70 169.23%
BIGG 0.22 15.79%
FNQ 0.01 %
ACDC 0.06 0.00%
RVV 0.01 %
FMAN 0.55 7.84%
TER 2.80 5.66%
GSK 0.54 20.00%
IP 0.12 -14.29%
USGD 0.16 14.29%
 
CN Canada Top Gainers Stocks
BTC 0.70 169.23%
BTC 0.70 169.23%
BTC 0.70 169.23%
BLR 0.02 100.00%
BLR 0.02 100.00%
BLR 0.02 100.00%
XCX 0.02 100.00%
MICH 0.13 62.50%
LLL 0.14 55.56%
LLL 0.14 55.56%
 
CN Canada Top Losers Stocks
GTG 0.37 -97.30%
GTG 0.37 -97.30%
MJRX 0.01 -50.00%
XBLK 0.02 -50.00%
SLZ 0.02 -50.00%
SLZ 0.02 -50.00%
SLZ 0.02 -50.00%
BAMM 0.02 -33.33%
CNTR 0.02 -33.33%
GOH 0.06 -33.33%
 
 
BIOV
Daily Charts		 BIOV
Intraday Charts		 Whats New @
Bazaartrend		 BIOV
Free Analysis
 
BIOV Important Levels Intraday
RESISTANCE0.09
RESISTANCE0.08
RESISTANCE0.08
RESISTANCE0.08
SUPPORT0.06
SUPPORT0.06
SUPPORT0.06
SUPPORT0.05
 
BIOV Forecast November 2024
Share
4th UP Forecast0.11
3rd UP Forecast0.1
2nd UP Forecast0.09
1st UP Forecast0.08
1st DOWN Forecast0.06
2nd DOWN Forecast0.05
3rd DOWN Forecast0.04
4th DOWN Forecast0.03
 
BIOV Weekly Forecast
4th UP Forecast0.11
3rd UP Forecast0.10
2nd UP Forecast0.09
1st UP Forecast0.08
1st DOWN Forecast0.06
2nd DOWN Forecast0.05
3rd DOWN Forecast0.04
4th DOWN Forecast0.03
 
BIOV Forecast2024
4th UP Forecast0.24
3rd UP Forecast0.19
2nd UP Forecast0.15
1st UP Forecast0.12
1st DOWN Forecast0.02
2nd DOWN Forecast-0.01
3rd DOWN Forecast-0.05
4th DOWN Forecast-0.1
 
 
BIOV Other Details
Segment EQ
Market Capital 33621936.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BIOV Address
BIOV
 
BIOV Latest News
 
Your Comments and Response on BioVaxys Technology Corp
 
BIOV Business Profile
BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. It develops BVX-0320, a monovalent SARS-CoV-2 vaccine; and BVX-0918A, a haptenized tumor antigen vaccine for ovarian cancer, as well as and Covid-T, which screens for an immune system response in patients exposed to SARS-CoV-2. The company is also developing Papilocare for human papilloma virus (HPV)-dependent cervical lesions; BVX-0918C for cervical cancer; BVX-0204 HPV viral vaccine; and BVX-0121, a multivalent SARS-CoV-2 vaccine. BioVaxys Technology Corp. has a bioproduction agreement with WuXi Biologics Limited that produces SARS-CoV-2 s-proteins for BVX-0320 and Covid-T; research collaboration with The Ohio State University, Wexner School of Medicine for BVX-0320; and agreement with Bioanalytical Systems, Inc. to conduct preclinical toxicology studies for its Covid-T immunodiagnostic. The company is headquartered in Vancouver, Canada. Address: 905 West Pender Street, Vancouver, BC, Canada, V6C 1L6
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service